2020
DOI: 10.1259/bjrcr.20190047
|View full text |Cite
|
Sign up to set email alerts
|

Multi-imaging study in a patient with cerebrotendinous xanthomatosis: radiology, clinic and pathology correlation of a rare condition

Abstract: Cerebrotendinous xanthomatosis (CTX) is a rare metabolic disease with autosomal recessive inheritance. It is caused by mutations of the CYP27A1 gene, which codifies for sterol 27-hydroxylase, an enzyme that is responsible for the synthesis of cholic acids. In CTX, cholic acid synthesis is impaired, leading to accumulation of the precursor chenodessossicholic acid) in various organs and tissues. The clinical manifestations of CTX include chronic diarrhea, early-onset cataracts, tendon xanthomas and neurological… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…Achilles tendon xanthomas have also been found associated with some types of hyperlipidemia and chromosome mutations or with non-FH. [6] Careful clinical assessment of the Achilles tendon often lacks sensitivity. Different imaging modalities have been used to evaluate these xanthomas such as radiographs of particular joints or regions, CT, MRI, and ultrasound.…”
Section: Discussionmentioning
confidence: 99%
“…Achilles tendon xanthomas have also been found associated with some types of hyperlipidemia and chromosome mutations or with non-FH. [6] Careful clinical assessment of the Achilles tendon often lacks sensitivity. Different imaging modalities have been used to evaluate these xanthomas such as radiographs of particular joints or regions, CT, MRI, and ultrasound.…”
Section: Discussionmentioning
confidence: 99%
“…Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive lipid deposition disorder characterized by systemic signs and neurological dysfunction[ 1 ]. CTX is a treatable genetic metabolic disease, and early diagnosis and treatment can delay the progression of the disease to a considerable extent[ 2 ].…”
Section: Introductionmentioning
confidence: 99%